Gender Effect on Some Blood Parameters in Patients Undergoing Haemodialysis in North Western Algeria

Mouna MEGHRAOUI; Achouak Kheira MEDDAH; Mustapha DIAF; Mohamed DIAF

doi:10.21467/ajgr.8.1.115-120

Authors

Mouna MEGHRAOUI Department of Biology, Faculty of Natural and Life Sciences, Djillali LIABES University of Sidi-Bel-AbbÃ¨s, Algeria
Achouak Kheira MEDDAH Department of Biology, Faculty of Natural and Life Sciences, Djillali LIABES University of Sidi-Bel-AbbÃ¨s, Algeria
Mustapha DIAF Biology Department, Faculty of Natural and Life Sciences, Djillali LIABES University of Sidi-Bel-AbbÃ¨s, Algeria https://orcid.org/0000-0001-6065-6659
Mohamed DIAF Nephrology and dialysis department, "BOURAS Miloud" Hospital of Tabia, Sidi-Bel-AbbÃ¨s, Algeria

DOI:

https://doi.org/10.21467/ajgr.8.1.115-120

Abstract

Replacement therapy for chronic kidney disease using haemodialysis involves the elimination of excessive toxic fluids and toxic metabolic end products from the body. Worldwide, gender significant differences exist with regard to the epidemiological aspect, evolution and blood parameters of chronic renal failure disease. In the present retrospective study, 289 medical files of adult patients (154 men and 135 women) aged 20 to 78 years were investigated to understand the relationship between gender difference and blood parameters in patients with chronic renal failure undergoing haemodialysis in north western Algeria. Our results revealed significant higher levels of haemoglobin (p=0.003), haematocrit (p=0.005), creatinine (p<0.001) and uric acid (p=0.037) in men comparing to women. However, women serum samples were characterized by higher significant level of platelets (p=0.002). No significant differences (p˃0.005) were observed between the two genders regarding the other parameters of blood count formula, liver function parameters, urea, mineral status (calcemia and phosphoremia), basic biochemical levels (glycaemia and lipids), C-reactive protein (CRP) and parathyroid hormone (PTH). In dialysis patients, and despite the fact that some serum parameters vary significantly, the majority of the parameters recorded were often high in the males compared to the female gender. This finding may be due to the existence of specific confounding prognostic factors for each sex, which may or may not compensate for each other, therefore, ultimately, leading to overall non-significance.

Keywords:

haemodialysis, blood parameters, gender difference, north western Algeria

Downloads

Download data is not yet available.

References

M. Miura, A. Hirayama, S. Oowada, A. Nishida, C. Saito, K. Yamagata, O. Ito, Y. Hirayama, M. Kohzuki, “Effects of electrical stimulation on muscle power and biochemical markers during hemodialysis in elderly patients: a pilot randomized clinical trial”, Renal Replacement Therapy, vol. 4, no. 33, pp. 1-8, Sep. 2018. https://doi.org/10.1186/s41100-018-0174-7

R. Nisha, S. R. S. Kannan, K. T. Mariappan, P. Jagatha, “Biochemical evaluation of creatinine and urea in patients with renal failure undergoing hemodialysis”, J. Clin. Path. Lab. Med., vol. 1, no. 2, pp. 1-5, Jul. 2017.

A. Rusul Arif, S. Haider, “A study of some biochemical changes in patients with chronic renal failure undergoing hemodialysis”, Int. J. Curr. Microbiol. App. Sci., vol. 3, no. 5, pp. 581-586, 2014.

S. Artan, F. Kircelli, E. Ok, M. Yilmaz, G. Asci, C. Dogan, O. Oto, K. Gunestepe, A. Basci, M. S. Sever, “Dialyzing women and men: does it matter? An observational study”, Clinical Kidney Journal, vol. 9, no. 3, pp. 486-493, Jun. 2016. doi: 10.1093/ckj/sfw013

S. Raghunandan, S. Deepak Kumar, M. Ram Lakhan, “Effectiveness of Self Instructional Module (SIM) on knowledge regarding home care management among patients with chronic renal failure undergoing haemodialysis at selected hospital of Punjab”, IOSR J. Nurs. Health Sci., vol. 5, no. 6, pp. 20-31, 2016.

W.P. Samaneka, G. Mandozana, W. Tinago, N. Nhando, N.M. Mgodi, M.F. Bwakura-Dangarembizi, M.W. Munjoma, Z.A.R. Gomo, Z.M. Chirenje, J.G. Hakim, “Adult Hematology and Clinical Chemistry Laboratory Reference Ranges in a Zimbabwean Population”, PLoS One, vol. 11, no. 11, e0165821, 2016. https://doi:10.1371/journal.pone.0165821

P. Gomani, A.T. Matubu, H.A. Mujuru, M.W. Munjoma, W. Tinago, G. Mandozana, J.G. Hakim, Z.A.R. Gomo, Z.M. Chirenje, “Hematological and Biochemical Laboratory Reference Intervals for Zimbabwean Adolescents”, Clin Lab, vol. 61, no. 1-2, pp. 101-111, 2015. https://doi:10.7754/clin.lab.2014.140506M.

Unruh, M. Kurella Tamura, B. Larive, A. Rastogi, S. James, B. Schiller, J. Gassman, C. Chan, R. Lockridge, A. Kliger, “Impact of sleep quality on cardiovascular outcomes in hemodialysis patients: results from the frequent hemodialysis network study”, Am. J. Nephrol., vol. 33, no. 5, pp. 398-406, 2011. doi: 10.1159/00032634.

M. Anees, Y. Hussain, M. Ibrahim, I. Ilahi, S. Ahmad, K.I. Asif, A. Jameel, “Outcome of Chronic Kidney Disease Patients on the Basis of Referral to Nephrologist: A One-Year Follow-up Study”, J Coll Physicians Surg Pak, vol. 28, no. 4, pp.304-307, 2018. doi:10.29271/jcpsp.2018.04.304.

R.J. McGonigle, J.D. Wallin, R.K. Shadduck, J.W. Fisher, “Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency”, Kidney Int, vol. 25, no. 2, pp. 437-444, 1984. doi:10.1038/ki.1984.36.

C.P. Kovesdy, B.K. Trivedi, K. Kalantar-Zadeh, J.E. Anderson, “Association of anemia with outcomes in men with moderate and severe chronic kidney disease”, Kidney Int, vol. 69, no. 3, pp. 560-564, 2006. doi:10.1038/sj.ki.5000105.

A. Muhammad, M. Zeb, M. Khan, H. Hayat, M. Hameed, A. Ullah, “Anemia in End Stage Renal Failure Patients”, Annals of Allied Health Sciences, vol. 4, no. 2, pp. 52-55, 2019.

N. Asif, S. Hasan, K. Hassan, “Hematological Changes in Patients of Chronic Renal Disease and Their Response to Treatment with Erythropoietin”, Int. j. pathol., vol. 13, no. 1, pp. 14-19, 2015.

J. Pandian, K. Amitkumar, A. Swaminathan, “Assessment of impact of hemodialysis on hematological parameters among patients with chronic kidney disease”, Comp. Clin. Pathol., vol. 26, pp. 213-218, Nov. 2017. https://doi.org/10.1007/s00580-016-2372-4.

K. Suega, M. Bakta, T. G. Dharmayudha, J. S. Lukman, K. Suwitra, “Profile of anemia in chronic renal failure patients: comparison between predialyzed and dialyzed patients at the Division of Nephrology, Department of Internal Medicine, Sanglah Hospital, Denpasar, Bali, Indonesia”, Acta Med. Indones., vol. 37, no. 4, pp. 190-194, Dec. 2005.

S. Bhatta, G Aryal, RK Kafle, “Anemia in chronic kidney disease patients in predialysis and postdialysis stages”, Journal of Pathology of Nepal, vol. 1, no. 1, pp. 26-29, 2011. https://doi.org/10.3126/jpn.v1i1.4446

E. P. Lopes, L. H. Sette, J. B. Sette, C. F. Luna, A. M. Andrade, M. Moraes, P. C. Sette, R. Menezes, R. L. Cavalcanti, S. C. Conceição, “Serum alanine aminotransferase levels, hematocrit rate and body weight correlations before and after hemodialysis session”, Clinics (Sao Paulo), vol. 64, no. 10, pp. 941-945, 2009. doi: 10.1590/S1807-59322009001000002.

J. E. Trevizoli, R. de Paula Menezes, L. F. Ribeiro Velasco, R. Amorim, M. B. de Carvalho, L. S. Mendes, C. J. Neto, J. R. de Deus Macedo, F. de Assis, R. Neves, “Hepatitis C is less aggressive in hemodialysis patients than in nonuremic patients”, Clin. J. Am. Soc. Nephrol., vol. 3, no. 5, pp. 1385-1390, Sep. 2008. doi: 10.2215/CJN.01330308.

L. Ray, S. K. Nanda, A. Chatterjee, R. Sarangi, S. Ganguly, “A comparative study of serum aminotransferases in chronic kidney disease with and without end-stage renal disease: Need for new reference ranges”, Int. J. Appl. Basic Med. Res., vol. 5, no. 1, pp. 31-35, Jan-Apr. 2015. doi: 10.4103/2229-516X.149232.

F. Fabrizi, G. Lunghi, S. Finazzi, P. Colucci, A. Pagano, C. Ponticelli, F. Locatelli, “Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis”, Am. J. Kidney Dis., vol. 38, no. 5, pp. 1009,1015, Nov. 2001.

J.H.D.A. van Beek, M.H.M. de Moor, E.J.C. de Geus, G.H. Lubke, J.M. Vink, G. Willemsen, D.I. Boomsma, “The Genetic Architecture of Liver Enzyme Levels: GGT, ALT and AST”, Behav Genet, vol. 43, no. 4, pp. 329-339, 2013. doi: 10.1007/s10519-013-9593-y.

N. Ul Amin, R. T. Mahmood, M. Javaid Asad, M. Zafar, A. M. Raja, “Evaluating Urea and Creatinine Levels in Chronic Renal Failure Pre and Post Dialysis: A Prospective Study”, Journal of Cardiovascular Disease, vol. 2, no. 2, 2014. http://www.researchpub.org/journal/jcvd/jcvd.html.

K. Yokoyama, M. Taniguchi, M. Fukagawa, “A Japanese approach for CKD-MBD”, Kidney international supplements, vol. 3, no. 5, pp. 451-456, 2013. https://doi.org/10.1038/kisup.2013.94.

A. Collinson, M. McMullan, W.Y. Tse, H. Sadler, “Managing serum phosphate in haemodialysis patients: time for an innovative approach?”, Eur J Clin Nutr, vol. 68, no. 3, pp. 392-396, 2014. doi:10.1038/ejcn.2013.283.

A. Gupta, L. R. Kallenbach, G. Zasuwa, W. Divine, “Race is a major determinant of secondary hyperparathyroidism in uremic patients”, J. Am. Soc. Nephrol., vol. 11, no. 2, pp. 330-334, Feb. 2000.